Long-Term Clinical Results Following Stenting of the Left Main Stem Insights From RESEARCH (Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital) and T-SEARCH (Taxus-Stent Evaluated at Rotterdam Cardiology Hospital) Registries

被引:49
|
作者
Onuma, Yoshinobu [1 ]
Girasis, Chrysafios [1 ]
Piazza, Nicolo [1 ]
Garcia-Garcia, Hector M. [1 ]
Kukreja, Neville [1 ]
Garg, Scot [1 ]
Eindhoven, Jannet [1 ]
Cheng, Jin-Ming [1 ]
Valgimigli, Marco [2 ]
van Domburg, Ron [1 ]
Serruys, Patrick W. [1 ]
机构
[1] Erasmus MC, Thoraxctr, NL-3015 CE Rotterdam, Netherlands
[2] Univ Ferrara, Cardiovasc Inst, I-44100 Ferrara, Italy
关键词
coronary disease; stents; atherosclerosis; PERCUTANEOUS CORONARY INTERVENTION; ASSOCIATION TASK-FORCE; ARTERY-DISEASE; AMERICAN-COLLEGE; SYNTAX SCORE; BARE-METAL; IMPLANTATION; BIFURCATION; GUIDELINES; OUTCOMES;
D O I
10.1016/j.jcin.2010.03.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We investigated the long-term clinical outcomes and independent predictors of major cardiac events in unprotected left main coronary artery disease (ULMCA) patients treated by percutaneous coronary intervention with drug-eluting stent (DES). Background There is limited information on long-term (>3 years) outcomes after DES implantation for ULMCA. Furthermore, bifurcation angle and SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score are emerging as parameters for patient risk stratification, and their prognostic implications have still to be elucidated. Methods One hundred forty-eight patients with ULMCA treated with DES were analyzed and compared with a historical cohort of 79 patients who received bare-metal stents for the treatment of ULMCA. Patient-oriented composite end point was defined as the occurrence of all-cause death, any myocardial infarction, or any revascularization. Results The 4-year cumulative incidence of all-cause death, any myocardial infarction, any revascularization, and patient-oriented composite were 35.6%, 3.8%, 25.2%, and 54.4%, respectively. These end points had relatively increased from 1 year to 4 years by Delta 70%, Delta 5%, Delta 50%, and Delta 68%, respectively. When compared with a historical cohort who received bare-metal stents for ULMCA treatment, landmark analysis performed after the first 2 years of follow-up demonstrated that the DES cohort had significantly higher patient-oriented composite end point over the last 2 years of follow-up (26% vs. 8%, p = 0.02). EuroSCORE (European System for Cardiac Operative Risk Evaluation), cardiogenic shock, and SYNTAX score were identified as independent predictors for the 4-year patient-oriented composite, whereas bifurcation angle was not. Conclusions Late increase in patient-oriented composite end points after DES implantation for ULMCA warrants careful and long-term follow-up. SYNTAX score and EuroSCORE appear to have a significant prognostic value in long-term patient risk. (J Am Coll Cardiol Intv 2010;3:584-94) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:584 / 594
页数:11
相关论文
共 44 条
  • [31] The Unrestricted Use of Everolimus-Eluting Stents for De-novo coronary lesions: The Xience V Stent Evaluated At Rotterdam Cardiology Hospital (X-SEARCH) Registry
    Onuma, Yoshinobu
    Kukreja, Neville
    van Domburg, Ron
    Daemen, Joost
    Gonazalo, Nieves
    Regar, Evelyn
    Duckers, Henricus J.
    van der Ent, Martin
    van Geuns, Robert Jan M.
    de Jaegere, Peter
    de Feyter, Pim J.
    van der Giessen, Wim
    Serruys, Patrick W.
    CIRCULATION, 2008, 118 (18) : S1044 - S1044
  • [32] The Unrestricted Use of Everolimus-Eluting Stents for De-novo Coronary Lesions: The Xience V Stent Evaluated at Rotterdam Cardiology Hospital (X-SEARCH) Registry
    Kukreja, Neville
    Onuma, Yoshinobu
    Eindhoven, Jannet
    Gaster, Anne-Louise
    Piazza, Nicolo
    Gonzalo-Lopez, Nieves
    Girasis, Christoforou
    Garcia-Garcia, Hector M.
    van Domburg, Ron T.
    Serruys, Patrick W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A394 - A394
  • [33] 6-month Clinical Outcome Following the Use of Everolimus-eluting Stents for ST-segment Elevation Myocardial Infarction: Insights From the Xience V Stent Evaluated At Rotterdam Cardiology Hospital (X-SEARCH) Registry
    Onuma, Yoshinobu
    Kukreja, Neville
    Garcia-Garcia, Hector
    Duckers, Henricus J.
    Regar, Evelyn
    van Geuns, Robert-Jan
    van der Ent, Martin
    van der Giessen, Wim
    de Feyter, Pim J.
    de Jaegere, Peter P. T.
    van Domburg, Ron
    Serruys, Patrick W. J. C.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 66I - 66I
  • [34] A quantitative coronary angiography-matched comparison between a prospective randomised multicentre cutting balloon angioplasty and bare metal stent trial (REDUCE III) and the Rapamycin-Eluting Stent Evaluation At Rotterdam Cardiology Hospital (RESEARCH) study
    Ozaki, Yukio
    Lemos, Pedro A.
    Yamaguchi, Tetsu
    Suzuki, Takahiko
    Nakamura, Masato
    Ismail, Tevfik F.
    Kitayama, Michihiko
    Nishikawa, Hideo
    Kato, Osamu
    Serruys, Patrick W.
    EUROINTERVENTION, 2010, 6 (03) : 400 - 406
  • [35] The Promus Premier everolimus-eluting platinum chromium Stent with durable polymer Evaluated in a real world All-comer population in Rotterdam Cardiology Hospital (the P-SEARCH registry)
    Lemmert, Miguel
    Van Mieghem, Nicolas
    van Geuns, Robert-Jan
    Diletti, Roberto
    Vandomburg, Ron
    Regar, Evelyn
    Zijlstra, Felix
    Boersma, Eric
    Daemen, Joost
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B180 - B180
  • [36] The Promus Premier everolimus-eluting platinum chromium stent with durable polymer evaluated in a real world all-comer population in Rotterdam cardiology hospital (the P-SEARCH registry)
    Lemmert, Miguel E.
    van Mieghem, Nicolas M.
    van Geuns, Robert-Jan
    Diletti, Roberto
    van Bommel, Rutger J.
    van Domburg, Ron T.
    de Jaegere, Peter P.
    Regar, Evelyn
    Zijlstra, Felix
    Boersma, Eric
    Daemen, Joost
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 240 : 103 - 107
  • [37] Unrestricted use of everolimus-eluting stents for de-novo coronary lesions: one-year clinical outcome of the Xience Stent Evaluated At Rotterdam Cardiology Hospital (X-SEARCH) registry
    Onuma, Y.
    Kukreja, N.
    Piazza, N.
    Girasis, C.
    Eindhoven, J.
    Van Domburg, R.
    Serruys, P. W.
    EUROPEAN HEART JOURNAL, 2009, 30 : 663 - 663
  • [38] Routine Fractional Flow Reserve Measurement after Percutaneous Coronary Intervention with a Novel FFR Micro Catheter, Insights from the FFR-SEARCH Registry - FFR Stent Evaluated at Rotterdam Cardiology Hospital
    van Bommel, Rutger
    Lemmert, Miguel
    Wang, Yan
    Daemen, Joost
    Regar, Evelyn
    Wilschut, Jeroen
    Zijlstra, Felix
    Diletti, Roberto
    Van Mieghem, Nicolas
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (18) : B217 - B217
  • [39] The impact of stent thrombosis on the long-term efficacy of drug-eluting stents in patients with acute myocardial infarction - Insights into the RESEARCH and T-SEARCH registries
    Daemen, Joost
    van Twisk, Piet Hein
    de Jaegere, Peter P. T.
    van Domburg, Ron T.
    Serruys, Patrick W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2007, 100 (8A): : 33L - 33L
  • [40] Long-term Outcomes After Treatment Of In-stent Restenosis With Bare-metal Stent And Drug-eluting Stent: Insights From Research And T-search Registry
    Onuma, Yoshinobu
    Kukureja, Neville
    Daemen, Joost
    Gonzalo, Nieves
    Regar, Evelyn
    Duckers, Henricus J.
    van Geuns, Robert Jan
    van der Ent, Martin
    de Jaegere, Peter
    de Feyter, Pim J.
    van der Giessen, Wim
    van Domburg, Ron
    Serruys, Patrick W.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 169I - 169I